Exploring ASX Life Sciences Companies Making an Impact
Two Australian biotech – pharma companies delivering for investors.
Recce Pharmaceuticals – working on the global health challenge of sepsis and superbugs
Some highlights from ASX companies in the past month
Antisense Therapeutics - a purpose driven biotech with global potential
Two leading Australian biotech companies working to solve global unmet needs
The global companies European investors are buying on Frankfurt Stock Exchange
Antisense Therapeutics Shares up 40% in a month. Strong Volume in Europe.
Major global trends driving biotech investment in 2021
A global biotech leader in synthetic anti-infectives dual lists in Germany
Antisense shares have increased by 60% after Sarepta results
mRNA and Antisense biotech - attracting the large fund managers and defining 2020
Immutep Limited - a global leader in development of immunotherapy for cancer & autoimmune diseases
Broker upgrades Antisense Therapeutics by 470%
Ionis Pharmaceuticals - A force for life
mRNA and RNA biotechnology – “The software of life”
Australian biotech companies becoming global players
Antisense Therapeutics Limited dual-lists in Europe